Nerea Escribano-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nerea Escribano-Rodríguez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- David Rodríguez de Vera Gómez
Podiatry Faculty, University of Seville, 41009 Seville, Spain
1 shared publication - Gabriel Gijon-Nogueron
Department of Nursing and Podiatry, Faculty of Health Sciences, University of Malaga, Arquitecto Francisco Penalosa 3, Ampliación de Campus de Teatinos, 29071 Malaga, Spain
1 shared publication - Luis María Gordillo Fernández
Department of Podiatry, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, 41009 Seville, Spain
1 shared publication - Mercedes Ortiz-Romero
Department of Podiatry, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, 41009 Seville, Spain
1 shared publication - Pablo Rodríguez de Vera Gómez
Department of Endocrinology and Nutrition, Virgen Macarena University Hospital, Seville, Spain
1 shared publication
Latest Publications
- Open Access
- 6 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1307
Effect of Local Laser Therapy on Plantar Fasciitis: A Meta-Analysis
Background/Objectives: Plantar fasciitis (PF) is a leading cause of heel pain and functional impairment in adults. Laser therapy, in its low-intensity laser therapy (LLLT), high-intensity laser therapy (HILT), and photobiomodulation (PBMT) modalities, has been proposed as a non-invasive alternative, although its clinical effectiveness remains a subject of debate. The aim of this systematic review and meta-analysis was to evaluate the efficacy of laser therapy in reducing pain, improving function, and modifying fascial thickness in patients with PF. Methods: A comprehensive search was conducted in PubMed, Embase, and PEDro (last search: August 2025). Randomized controlled trials comparing laser therapies versus placebo or alternative physical interventions were included. Two reviewers performed study selection, data extraction, and risk of bias assessment using the PEDro scale. Random-effects meta-analyses were performed for pain (VAS), heel tenderness (HTI), function (FFI, AOFAS, ASQoL, SF-36), and fascial thickness, expressing effects as standardized mean differences (SMDs) or mean differences (MDs). Results: Thirteen trials with 784 participants were included. Laser therapy showed a significant improvement in heel tenderness (SMD = −0.40; 95% CI −0.71 to −0.09; I2 = 0%). No significant differences were observed in overall pain (SMD = −0.18), function (SMD = 0.20), or fascial thickness (MD = −0.18 mm). Pain and function analyses showed high heterogeneity. Conclusions: Laser therapy may reduce heel tenderness in plantar fasciitis, but it does not consistently improve overall pain, function, or fascial thickness. Its use should be considered as a therapeutic adjunct and not as a primary intervention. Larger trials with standardized protocols are needed.
- 6 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1307
Open AccessEffect of Local Laser Therapy on Plantar Fasciitis: A Meta-Analysis
Background/Objectives: Plantar fasciitis (PF) is a leading cause of heel pain and functional impairment in adults. Laser therapy, in its low-intensity laser therapy (LLLT), high-intensity laser therapy (HILT), and photobiomodulation (PBMT) modalities, has been proposed as a non-invasive alternative, although its clinical effectiveness remains a subject of debate. The aim of this systematic review and meta-analysis was to evaluate the efficacy of laser therapy in reducing pain, improving function, and modifying fascial thickness in patients with PF. Methods: A comprehensive search was conducted in PubMed, Embase, and PEDro (last search: August 2025). Randomized controlled trials comparing laser therapies versus placebo or alternative physical interventions were included. Two reviewers performed study selection, data extraction, and risk of bias assessment using the PEDro scale. Random-effects meta-analyses were performed for pain (VAS), heel tenderness (HTI), function (FFI, AOFAS, ASQoL, SF-36), and fascial thickness, expressing effects as standardized mean differences (SMDs) or mean differences (MDs). Results: Thirteen trials with 784 participants were included. Laser therapy showed a significant improvement in heel tenderness (SMD = −0.40; 95% CI −0.71 to −0.09; I2 = 0%). No significant differences were observed in overall pain (SMD = −0.18), function (SMD = 0.20), or fascial thickness (MD = −0.18 mm). Pain and function analyses showed high heterogeneity. Conclusions: Laser therapy may reduce heel tenderness in plantar fasciitis, but it does not consistently improve overall pain, function, or fascial thickness. Its use should be considered as a therapeutic adjunct and not as a primary intervention. Larger trials with standardized protocols are needed.